Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
60.28 USD | +1.43% | +1.77% | -7.46% |
Mar. 19 | Azenta Seeks Tuck-In M&A | CI |
Mar. 19 | Transcript : Azenta, Inc. Presents at KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum, Mar-19-2024 12:45 PM |
Financials (USD)
Sales 2024 * | 704M | Sales 2025 * | 743M | Capitalization | 3.36B |
---|---|---|---|---|---|
Net income 2024 * | -27M | Net income 2025 * | -17M | EV / Sales 2024 * | 4.78 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 4.53 x |
P/E ratio 2024 * |
-96.6
x | P/E ratio 2025 * |
-126
x | Employees | 3,500 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 79.02% |
Latest transcript on Azenta, Inc.
1 day | +1.43% | ||
1 week | +2.71% | ||
Current month | -7.48% | ||
1 month | -7.42% | ||
3 months | -9.08% | ||
6 months | +25.85% | ||
Current year | -7.46% |
Managers | Title | Age | Since |
---|---|---|---|
Stephen Schwartz
CEO | Chief Executive Officer | 65 | 10-04-04 |
Herman Cueto
DFI | Director of Finance/CFO | 50 | 23-10-15 |
Michael Paulo
CTO | Chief Tech/Sci/R&D Officer | - | 17-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Martin Madaus
BRD | Director/Board Member | 63 | Jan. 29 |
Edward Bousa
BRD | Director/Board Member | 65 | Jan. 29 |
Stephen Schwartz
CEO | Chief Executive Officer | 65 | 10-04-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.74% | 149 M€ | +6.21% | - | |
0.90% | 5 M€ | -1.80% | - | |
0.38% | 2 M€ | -.--% | ||
0.21% | 15 M€ | +7.68% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 60.28 | +1.43% | 367,329 |
24-03-27 | 59.43 | +1.78% | 331,851 |
24-03-26 | 58.39 | +0.99% | 346,623 |
24-03-25 | 57.82 | -2.51% | 393,058 |
24-03-22 | 59.31 | +0.14% | 516,466 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.46% | 3.31B | |
+9.30% | 45.97B | |
+52.73% | 43.93B | |
+7.15% | 42.34B | |
-8.78% | 28.27B | |
+18.68% | 27.18B | |
-21.92% | 19.44B | |
+14.62% | 13.83B | |
+31.85% | 12.4B | |
+4.47% | 11.45B |